Category: Volume 2, Issue 1
Highlighting hypertriglyceridemia with a case of l...
Posted by Emily Humphreys, OD, FAAO and Thomas Andrea OD, FAAO | Feb 24, 2024 | Retina, Systemic Disease, Volume 2, Issue 1 | 0 |
Diagnosing Macular Telangiectasia Type 2
Posted by Pete Thomas Liette, OD, FAAO, Brett Garee OD, MS, FAAO and Rachele Liette, OD | Feb 23, 2024 | Retina, Volume 2, Issue 1 | 0 |
Torpedo Maculopathy
Posted by Adam Provost, OD | Feb 23, 2024 | Retina, Volume 2, Issue 1 | 0 |
Sarcoid-Induced Uveitis: A Tattooed Journey
Posted by Simmy Panchal, OD, FAAO, Dipl. ABO and Kelly Singleton, OD, MS | Feb 21, 2024 | Systemic Disease, Uveitis, Volume 2, Issue 1 | 0 |
PHOTO ESSAY: “New” Red Eye – A Case of Conjunctival Intraepithelial Neoplasia
by Steve Njeru, OD, MS, FAAO and Karina Miller, OD, MS | Feb 25, 2024 | Conjunctiva, Volume 2, Issue 1
Ocular surface squamous neoplasia (OSSN) covers a wide range of ocular diseases that affect the squamous epithelial cells on the surface of the eye. This includes conjunctival intraepithelial neoplasia, corneal epithelial dysplasia, squamous cell carcinoma, and mucoepidermoid carcinoma. Anterior segment OCT can be used to differentiate between CIN and other benign conjunctival lesions, by evaluating for epithelial activity, stromal invasion, and corneal involvement.
Read MoreHighlighting hypertriglyceridemia with a case of lipemia retinalis
by Emily Humphreys, OD, FAAO and Thomas Andrea OD, FAAO | Feb 24, 2024 | Retina, Systemic Disease, Volume 2, Issue 1
Severe hypertriglyceridemia can transiently cause the appearance of a salmon-colored fundus with creamy vessels which is known as lipemia retinalis
Read MoreDiagnosing Macular Telangiectasia Type 2
by Pete Thomas Liette, OD, FAAO, Brett Garee OD, MS, FAAO and Rachele Liette, OD | Feb 23, 2024 | Retina, Volume 2, Issue 1
MacTel type 2 is the most common subtype that results in atrophic changes and sometimes subretinal neovascularization (SRN). This case report will focus on a patient with MacTel type 2 and the management and treatment options pertinent to the case.
Read MoreTorpedo Maculopathy
by Adam Provost, OD | Feb 23, 2024 | Retina, Volume 2, Issue 1
Torpedo maculopathy is a rare condition resulting in malformation of the outer retina. These lesions are often asymptomatic and found incidentally during routine eye examination. Although typically benign, there are rare reports of associated complications requiring treatment. Appropriate monitoring is thus required.
Read MoreRecurrent Conjunctival Squamous Papilloma
by Mary Wittendorf, O.D. F.A.A.O, Carla Gilbertson Kuiken, O.D., FAAO and Erica Vanderpool, OD, FAAO | Feb 22, 2024 | Conjunctiva, Volume 2, Issue 1
This case features a 76-year-old Caucasian male with a conjunctival squamous papilloma regrowth. The initial lesion was removed via excisional…
Read MoreCharles Bonnet Syndrome Precipitated by Brimonidine Tartrate
by Shelly Kim, OD. FAAO | Feb 22, 2024 | Featured Article, Glaucoma, Neuro, Systemic Disease, Volume 2, Issue 1
Charles Bonnet Syndrome (CBS) induced by brimonidine tartrate ophthalmic solution has rarely been reported. CBS is a condition characterized by visual hallucinations in patients with vision loss and clear cognition. This condition is more prevalent in the elderly population, between the ages of 75 and 84 years old.
Read MoreA Review of the Management of Fuchs Endothelial Corneal Dystrophy
by Jamie Hogan, OD, | Feb 22, 2024 | Cornea, Volume 2, Issue 1
Fuchs Endothelial Corneal Dystrophy leads to progressive visual deterioration that may cause acutely painful episodes. Medical management has been limited to prescribing hyperosmotic agents. The advancement in therapeutic and surgical management has led to earlier intervention, better visual prognosis, and improved quality of life for patients affected by FECD. Optometrists play a role in the management of this condition’s diagnosis, treatment, and postsurgical care.
Read MoreMultitasking
by Doug Rett OD, FAAO, ABCMO | Feb 22, 2024 | Editor's Column, Volume 2, Issue 1
It’s 2024 and we welcome you to the Volume 2 of the Journal of Medical Optometry. 2023 was our inaugural year and we grew by virtually every metric…
Read MoreWhat Evidence Based Medicine is Not: Part 2
by Kyle D Klute, OD, FAAO | Feb 22, 2024 | Follow the Science, Volume 2, Issue 1
How do we, as busy clinicians in the trenches of patient care, appraise and apply EBM to our practice? If you’ve read all that I’ve written on this topic…
Read MoreSymptomatic Carotid Artery Stenosis Presenting with Visual Field Deficits Managed via Transcervical Carotid Artery Revascularization
by Joseph Kane OD, FAAO, Michelle C Martin, MD and Carlota Andreu-Arasa MD, PhD | Feb 22, 2024 | Neuro Nuggets, Volume 2, Issue 1
A 79-y.o. white male presented for evaluation complaining of trouble seeing in his peripheral vision while driving for the preceding two weeks…
Read MoreSarcoid-Induced Uveitis: A Tattooed Journey
by Simmy Panchal, OD, FAAO, Dipl. ABO and Kelly Singleton, OD, MS | Feb 21, 2024 | Systemic Disease, Uveitis, Volume 2, Issue 1
When a patient presents with an anterior uveitis that is suspicious for a systemic etiology, it is important to explore all areas of clinical care to determine the cause. Traditionally, the initial approach is to perform an appropriate lab work-up. Beyond this, areas of specialty that are typically considered include rheumatology, radiology, and infectious disease. However, this case report will present a patient that required intervention from dermatology to confirm the source of ocular inflammation.
Read MoreSubscribe
JoMO Newsletter
Sign up to get notified when new articles are published.
Thank you!
You have successfully joined our subscriber list.